• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

    0.4730 -0.0103 (-2.13%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 121,725
    Open 0.4600
    Bid (Size) 0.4451 (1,300)
    Ask (Size) 0.4963 (200)
    Prev. Close 0.4833
    Today's Range 0.4500 - 0.4798
    52wk Range 0.4351 - 3.420
    Shares Outstanding 40,784,731
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire

    Performance

    YTD
    -58.1%
    -58.1%
    1 Month
    -56.6%
    -56.6%
    3 Month
    -79.9%
    -79.9%
    6 Month
    -81.8%
    -81.8%
    1 Year
    -66.6%
    -66.6%

    More News

    Read More
    News headline image
    Anebulo Pharmaceuticals Announces Final Results of Tender Offer
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It ↗
    Via Benzinga
    News headline image
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    News headline image
    Top movers in Friday's pre-market session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    On Thursday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings ↗
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
    From Anebulo Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Anebulo Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Anebulo Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Anebulo Pharmaceuticals, Inc. - Common Stock trade on?
    Anebulo Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock is ANEB on the Nasdaq Stock Market
    What is the current price of Anebulo Pharmaceuticals, Inc. - Common Stock?
    The current price of Anebulo Pharmaceuticals, Inc. - Common Stock is 0.4730
    When was Anebulo Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Anebulo Pharmaceuticals, Inc. - Common Stock was at 02/20/26 04:00 PM ET
    What is the market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock is 19.29M
    How many shares of Anebulo Pharmaceuticals, Inc. - Common Stock are outstanding?
    Anebulo Pharmaceuticals, Inc. - Common Stock has 19M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.